▶️PORIB ha estado presente en el Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR), celebrado en Viena del 8 al 10 de noviembre, con las comunicaciones: Clinical and economic value of seladelpar in combination with ursodeoxycholic acid for the treatment of Primary Biliary Cholangitis in Spain y Cost-effectiveness analysis of expanded influenza vaccination coverage with live attenuated influenza vaccine (LAIV) in children aged 2-11 years in Catalonia (Spain).
